 Home > Active Ingredient News > Immunology News > Promote the individualized chronic disease management of RA from four dimensions to achieve "long-term security"

Promote the individualized chronic disease management of RA from four dimensions to achieve "long-term security"

 Last Update: 2021-03-25
 Source: Internet
 Author: User

Tags

2 3 pentanedione

management companies

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

*Only for medical professionals to read for reference.
How to individualize chronic disease management for RA patients? References: [1]Jin S,Li M,Fang Y,et al.
Chinese Registry of rheumatoid arthritis (CREDIT):II.
prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis[J].
Arthritis Research & Therapy ,2017,19(1):251.
[2]Yu C, Li M, Duan X, et al.
Chinese registry of rheumatoid arthritis (CREDIT): I.
Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis[J] .
Clin Exp Rheumatol,2018,36(5):836-840.
[3] National Nursing Cooperative Group for Chronic Disease Management of Rheumatoid Immune Diseases.
Expert consensus on chronic disease management of patients with rheumatoid arthritis (2014 edition)[J].
Journal of Rheumatology,2016,20(2):127-131.
[4]Bakker MF,Jacobs JW,Welsing PM,et al.
Early clinical response to treatment predicts 5-year outcome in RA patients:follow-up results from the CAMERA study[J].
Ann Rheum Dis,2011,70(6):1099-103.
[5],

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Purity 99% BPN14770 Zatolmilast 1606974-33-7 In Stock Fast Ship to USA

CAS No.: 1606974-33-7

Pharm Grade

$1-1.1/UNIT FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Top quantity Imiquimod CAS NO 99011-02-6 White crystalline powder 99% API

CAS No.: 99011-02-6

Pharmacy Grade

$1800-1850/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.